In addition, our results highlighted that ANKFN1 functions as a regulator of HCC progression by regulating the MEK/ERK/c-Myc/cyclin D1/Cdk4/Cdk6 pathway. This evidence concerns the gene CDK4 and hepatocellular carcinoma.